Table 1.

Demographic characteristics of the included studies in the meta-analysis of the effect of soy intake on NAFLD patients

First author	Publication year	Country	Mean age	Sample size	Duration	Intervention	Control
Kani	2014	Iran	48.5	15 / 15	8 weeks	Low-Calorie, low-carbohydrate soy-containing	Low-calorie, low-carbohydrate
Amanat	2018	Iran	44.22	41 / 37	8 weeks	Genistein	Placebo
Eslami	2019	Iran	46.25	32 / 32	8 weeks	Soy milk	Consumption not soy-based products
Maleki	2019	Iran	46.16	31 / 31	8 weeks	Soy milk	Consumption not soy-based products